These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10807877)

  • 1. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel.
    Veldkamp MW; Viswanathan PC; Bezzina C; Baartscheer A; Wilde AA; Balser JR
    Circ Res; 2000 May; 86(9):E91-7. PubMed ID: 10807877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UltraRapid communications : vascular superoxide production by NAD(P)H OxidaseAssociation with endothelial dysfunction and clinical risk factors.
    Guzik TJ; West NE; Black E; McDonald D; Ratnatunga C; Pillai R; Channon KM
    Circ Res; 2000 May; 86(9):1008. PubMed ID: 10807875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
    Wang DW; Makita N; Kitabatake A; Balser JR; George AL
    Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
    Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
    J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism.
    Clancy CE; Rudy Y
    Circulation; 2002 Mar; 105(10):1208-13. PubMed ID: 11889015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation.
    Makita N; Horie M; Nakamura T; Ai T; Sasaki K; Yokoi H; Sakurai M; Sakuma I; Otani H; Sawa H; Kitabatake A
    Circulation; 2002 Sep; 106(10):1269-74. PubMed ID: 12208804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel.
    Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL
    Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited sodium channelopathies: a continuum of channel dysfunction.
    Viswanathan PC; Balser JR
    Trends Cardiovasc Med; 2004 Jan; 14(1):28-35. PubMed ID: 14720472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
    Wang DW; Yazawa K; George AL; Bennett PB
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes.
    Rivolta I; Abriel H; Tateyama M; Liu H; Memmi M; Vardas P; Napolitano C; Priori SG; Kass RS
    J Biol Chem; 2001 Aug; 276(33):30623-30. PubMed ID: 11410597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN5A channelopathies--an update on mutations and mechanisms.
    Zimmer T; Surber R
    Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
    Potet F; Beckermann TM; Kunic JD; George AL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiac sodium channel: gating function and molecular pharmacology.
    Balser JR
    J Mol Cell Cardiol; 2001 Apr; 33(4):599-613. PubMed ID: 11273715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
    Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
    Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential calcium sensitivity in Na
    Abdelsayed M; Baruteau AE; Gibbs K; Sanatani S; Krahn AD; Probst V; Ruben PC
    J Physiol; 2017 Sep; 595(18):6165-6186. PubMed ID: 28734073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A.
    Calloe K; Schmitt N; Grubb S; Pfeiffer R; David JP; Kanter R; Cordeiro JM; Antzelevitch C
    Can J Physiol Pharmacol; 2011 Oct; 89(10):723-36. PubMed ID: 21895525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.